D-0482-2017 Class II Terminated
FDA drug recall D-0482-2017 was initiated by RemedyRepack Inc. on Feb 7, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated May 5, 2017). Affected quantity: 630 pills (21 bottles x 30 pills per HDPE bottle).
Recall details
- Product Type
- Drugs
- Report Date
- Mar 1, 2017
- Initiation Date
- Feb 7, 2017
- Termination Date
- May 5, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 630 pills (21 bottles x 30 pills per HDPE bottle)
Product description
Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Product was distributed to a sold customer in FL.
Code information
Lot # B0129373-021916; Exp. 10/17 00591-0900-30 Original NDC 52125-0764-02 RemedyRepack NDC
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0482-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026